Publication | Open Access

Cell therapy with autologous bone marrow mononuclear stem cells is associated with superior cardiac recovery compared with use of nonmodified mesenchymal stem cells in a canine model of chronic myocardial infarction

Regenerative MedicineCell TherapyCellular TherapiesMedicineSuperior Cardiac RecoveryAdult Stem CellImmunologyCardiac RegenerationChronic Myocardial InfarctionStem-cell TherapyBiomedical EngineeringMesenchymal Stem CellStem CellsCell TransplantationCardiologyCell Engineering